ArticleBioengineering (Basel, Switzerland)2026
From Infancy to Aging: Precise Brain Age Estimation via Hybrid CoTResNet3D and CrossViT Models on T1-Weighted Imaging.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate estimation of brain age from structural magnetic resonance imaging (MRI) serves as a vital biomarker for quantifying individual neurobiological aging and identifying risks for neurological disorders. However, developing robust models that generalize across the entire lifespan (from infancy to aging) remains challenging due to heterogeneous maturation/degeneration patterns, limited cross-center generalizability, and insufficient temporal reliability evaluation. To address these limitations, we curated a large-scale, multi-center T1-weighted MRI dataset across 27 public cohorts. Of these, 22,271 scans from 17 cohorts (aged 0-96 years) formed the primary foundation for model development, complemented by 10 additional cohorts utilized for independent multi-center evaluation and robustness testing. We propose ResNet-CrossViT, a novel hybrid architecture that synergistically combines a 3D Contextual Transformer-ResNet (CoTResNet3D) backbone for enriched local feature extraction and a CrossVision Transformer (CrossViT) module for cross-scale global dependency modeling. The model was rigorously evaluated on an internal test set, an unseen external dataset for cross-center validation, a longitudinal dataset for assessing temporal consistency, and a test-retest dataset for measuring reproducibility. On the internal test set, ResNet-CrossViT achieved a mean absolute error (MAE) of 2.72 years and a maximal MAE (mMAE) of 5.10 years, demonstrating marked performance improvements, particularly within the challenging adolescent cohort. The model maintained strong generalization on the unseen dataset (MAE = 4.19 years) and exhibited superior longitudinal consistency (Mean Absolute Difference Error, MAdE = 3.68) and excellent test-retest reliability (Intraclass Correlation Coefficient, ICC = 0.994). By integrating a large-scale, heterogeneous lifespan dataset with a hybrid architecture that effectively captures both local structural details and global long-range interactions, our study provides a precise, generalizable, and reliable framework for brain age estimation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.